Medical Market Report

Global DNA and Gene Chip Market By Type (Oligonucleotide DNA microarrays (oDNA), and Complementary DNA microarrays (cDNA)), By Application (Gene expression, Cancer diagnostics & treatments, Drug discovery, Genetics, and SNP analysis), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136339
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on DNA and Gene Chip Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global dna and gene chip market is segmented on the basis of Type, Application, and geography.

    The worldwide market for DNA and Gene Chip Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Global DNA and Gene Chip Market Scope:

    By type, the market is segmented into Oligonucleotide DNA microarrays (oDNA), and Complementary DNA microarrays (cDNA). By Application, the market is divided into Gene expression, Cancer diagnostics & treatments, Drug discovery, Genetics, and SNP analysis.

    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include AFFYMETRIX INC, AGILENT TECHNOLOGIES INC, BIOMIEUX SA, BIOMETRIX TECHNOLOGY INC, BIONEER CORP, CAPITALBIO CORP, EUROFINS MWG OPERON, GREINER BIO-ONE, ILLUMINA INC, LC SCIENCES, LIFEGEN TECHNOLOGIES, LIFE TECHNOLOGIES CORP, MACROGEN INC, MICROARRAYS INC, NGK INSULATORS LTD, ROCHE NIMBLEGEN INC, and SIGMA-ALDRICH.

    Key Market Segments

    Type

    Oligonucleotide DNA microarrays (oDNA)
    Complementary DNA microarrays (cDNA)

    Application

    Gene expression
    Cancer diagnostics & treatments
    Drug discovery
    Genetics
    SNP analysis

    Key Market Players included in the report:

    AFFYMETRIX INC
    AGILENT TECHNOLOGIES INC
    BIOMIEUX SA
    BIOMETRIX TECHNOLOGY INC
    BIONEER CORP
    CAPITALBIO CORP
    EUROFINS MWG OPERON
    GREINER BIO-ONE
    ILLUMINA INC
    LC SCIENCES
    LIFEGEN TECHNOLOGIES
    LIFE TECHNOLOGIES CORP
    MACROGEN INC
    MICROARRAYS INC
    NGK INSULATORS LTD
    ROCHE NIMBLEGEN INC
    SIGMA-ALDRICH

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and DNA and Gene Chip Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of DNA and Gene Chip Market; high-growth regions; and market drivers, restraints, and also market chances.

    The analysis covers DNA and Gene Chip Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global DNA and Gene Chip Market across sections such as also Application and representatives.

    Additionally, the analysis also has a comprehensive review of the crucial players on the DNA and Gene Chip Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the DNA and Gene Chip Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of DNA and Gene Chip sub-markets, depending on key regions (various vital states).
    To analyze DNA and Gene Chip Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the DNA and Gene Chip Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide DNA and Gene Chip Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. DNA and Gene Chip Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global DNA and Gene Chip Market Overview
    

    3.1. DNA and Gene Chip Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global DNA and Gene Chip Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global DNA and Gene Chip Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Oligonucleotide DNA microarrays (oDNA)
    

      4.4. Complementary DNA microarrays (cDNA)5. Global DNA and Gene Chip Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global DNA and Gene Chip Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Gene expression
    

      5.4. Cancer diagnostics & treatments
    

      5.5. Drug discovery
    

      5.6. Genetics
    

      5.7. SNP analysis6. Global DNA and Gene Chip Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America DNA and Gene Chip Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe DNA and Gene Chip Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific DNA and Gene Chip Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America DNA and Gene Chip Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa DNA and Gene Chip Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global DNA and Gene Chip Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. AFFYMETRIX INC
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. AGILENT TECHNOLOGIES INC
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. BIOMIEUX SA
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. BIOMETRIX TECHNOLOGY INC
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. BIONEER CORP
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. CAPITALBIO CORP
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. EUROFINS MWG OPERON
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. GREINER BIO-ONE
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. ILLUMINA INC
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. LC SCIENCES
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. LIFEGEN TECHNOLOGIES
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. LIFE TECHNOLOGIES CORP
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. MACROGEN INC
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments  7.16. MICROARRAYS INC
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments  7.17. NGK INSULATORS LTD
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments  7.18. ROCHE NIMBLEGEN INC
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments  7.19. SIGMA-ALDRICH
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.